A Phase 1/2 Study of Donafenib in Combination With KN046 in Advanced Gastrointestinal Tumors

Clinical trial NCT04612712 · TERMINATED

Trial details

NCT number: NCT04612712
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Gastrointestinal Tumors

Start date: 2021-01-19
Primary completion: 2022-06-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.